Tocqueville Asset Management’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-2,400
| Closed | -$472K | – | 587 |
|
2022
Q3 | $472K | Hold |
2,400
| – | – | 0.01% | 453 |
|
2022
Q2 | $514K | Sell |
2,400
-23
| -0.9% | -$4.93K | 0.01% | 487 |
|
2022
Q1 | $688K | Sell |
2,423
-6
| -0.2% | -$1.7K | 0.01% | 477 |
|
2021
Q4 | $915K | Hold |
2,429
| – | – | 0.01% | 472 |
|
2021
Q3 | $1M | Hold |
2,429
| – | – | 0.01% | 446 |
|
2021
Q2 | $899K | Buy |
2,429
+19
| +0.8% | +$7.03K | 0.01% | 462 |
|
2021
Q1 | $698K | Sell |
2,410
-9
| -0.4% | -$2.61K | 0.01% | 497 |
|
2020
Q4 | $604K | Buy |
2,419
+19
| +0.8% | +$4.74K | 0.01% | 509 |
|
2020
Q3 | $543K | Hold |
2,400
| – | – | 0.01% | 476 |
|
2020
Q2 | $418K | Hold |
2,400
| – | – | 0.01% | 520 |
|
2020
Q1 | $303K | Hold |
2,400
| – | – | 0.01% | 538 |
|
2019
Q4 | $367K | Buy |
+2,400
| New | +$367K | 0.01% | 607 |
|
2018
Q4 | – | Sell |
-2,948
| Closed | -$397K | – | 761 |
|
2018
Q3 | $397K | Sell |
2,948
-130
| -4% | -$17.5K | 0.01% | 652 |
|
2018
Q2 | $346K | Buy |
3,078
+8
| +0.3% | +$899 | ﹤0.01% | 667 |
|
2018
Q1 | $328K | Buy |
3,070
+310
| +11% | +$33.1K | ﹤0.01% | 691 |
|
2017
Q4 | $302K | Buy |
+2,760
| New | +$302K | ﹤0.01% | 700 |
|
2014
Q3 | – | Sell |
-1,500
| Closed | -$80K | – | 939 |
|
2014
Q2 | $80K | Hold |
1,500
| – | – | ﹤0.01% | 1212 |
|
2014
Q1 | $91K | Hold |
1,500
| – | – | ﹤0.01% | 944 |
|
2013
Q4 | $80K | Buy |
+1,500
| New | +$80K | ﹤0.01% | 969 |
|
2013
Q3 | – | Sell |
-7,650
| Closed | -$314K | – | 928 |
|
2013
Q2 | $314K | Buy |
+7,650
| New | +$314K | ﹤0.01% | 765 |
|